We called on you to share your view on corporate venture capital in the life science industries. Hundreds of you have answered, taking the survey and sharing your experiences and points of view on fund-raising in areas of medical devices, pharmaceuticals, biotech and diagnostics.
But we want more. We have until Friday to get responses to MedCity News’ survey on investing and corporate venture capital. So please take the survey.
This survey is in one part a hard look at the world of life science corporate VCs. But we’ll also ask you about the best investment opportunities overall in today’s world.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
In the survey you will see a a list of the 50 most prominent companies consistently investing in pharma, biotech and medical device. We know there are more. So we want to hear from you on the life science corporate VCs you know, have dealt with, and what your thoughts are on the modern environment for fund-raising in the life sciences.
You can take the survey by clicking here. Thank you for helping us support early-stage innovators by sharing your insights.
[Photo from Flickr user Philo Nordlund]
